Meatly Raises £10.4 Million in Series A Funding to Expand Cultivated Meat Operations

Meatly, a London-based biotech company focused on cultivated meat for pets and animals, has raised £10.4 million in a Series A funding round.

Investors in the round included Oyster Bay Venture Capital, Clean Growth Fund, and JamJar Investments.

The company said it will use the funding to expand operations and continue product development efforts.

Meatly Focuses on Cultivated Meat Production

Founded in 2021, Meatly develops cultivated meat using animal cells instead of traditional livestock farming methods. The company produces meat in laboratory environments by growing real animal cells in controlled conditions.

Owen Ensor leads the company.

According to Meatly, its cultivated chicken product is developed using a small sample of cells taken from a chicken egg. These cells are then combined with nutrient-rich liquid inside a bioreactor to produce animal protein that is biologically similar to conventional meat.

Alternative to Traditional Meat Production

The company said its production process is designed to reduce dependence on conventional meat supply chains. In addition, the cultivated meat is produced without animal slaughter and in sterile environments that do not require antibiotics.

Meatly also stated that the approach may reduce land and water usage compared to traditional industrial farming systems.

Funding to Support Expansion

The latest funding will support Meatly’s operational growth and research activities as the company continues to scale its cultivated meat platform.

The broader cultivated meat sector has seen increasing investment in recent years as companies explore alternative protein production methods focused on sustainability and animal welfare.